4 3 1 a r t I C l e S Fragile X syndrome (FXS) is the most common inherited form of intellectual disability and a leading genetic cause of autism 1,2 . FXS is caused by transcriptional silencing of the FMR1 gene, which encodes fragile X mental retardation protein (FMRP)-an RNA-binding protein that regulates translation of its interacting mRNAs 2 . Most people with FXS show many neurological deficits, including low intelligence quotient, seizures, sensory hypersensitivity, social anxiety, hyperactivity and other characteristics of autism 3, 4 . In the mouse model of FXS, Fmr1 knockout, plasticity that is dependent on group 1 metabotropic receptor (mGluR1 and mGluR5) stimulation of protein synthesis is enhanced and dysregulated 5 . These findings motivated the 'mGluR theory of FXS' , which posits that altered mGluR-dependent plasticity contributes to the pathophysiology of the disease [6] [7] [8] . In support of the mGluR theory, many phenotypes in animal models of FXS are reversed by pharmacological or genetic reduction of mGluR5 or downstream signaling pathways 7, 8 . Notably, a recent report indicates that mGluR5 antagonism can be an effective therapeutic strategy in patients with FXS 9 .
a r t I C l e S Fragile X syndrome (FXS) is the most common inherited form of intellectual disability and a leading genetic cause of autism 1, 2 . FXS is caused by transcriptional silencing of the FMR1 gene, which encodes fragile X mental retardation protein (FMRP)-an RNA-binding protein that regulates translation of its interacting mRNAs 2 . Most people with FXS show many neurological deficits, including low intelligence quotient, seizures, sensory hypersensitivity, social anxiety, hyperactivity and other characteristics of autism 3, 4 . In the mouse model of FXS, Fmr1 knockout, plasticity that is dependent on group 1 metabotropic receptor (mGluR1 and mGluR5) stimulation of protein synthesis is enhanced and dysregulated 5 . These findings motivated the 'mGluR theory of FXS' , which posits that altered mGluR-dependent plasticity contributes to the pathophysiology of the disease [6] [7] [8] . In support of the mGluR theory, many phenotypes in animal models of FXS are reversed by pharmacological or genetic reduction of mGluR5 or downstream signaling pathways 7, 8 . Notably, a recent report indicates that mGluR5 antagonism can be an effective therapeutic strategy in patients with FXS 9 .
Group 1 mGluR activation stimulates de novo protein synthesis in neurons, and evidence suggests that FMRP suppresses translation of specific mRNA targets downstream of mGluR activation 2 . In FXS, the loss of an FMRP-mediated 'brake' is proposed to lead to excess mGluR5-driven translation of many FMRP target mRNAs, which in turn leads to an excess of mGluR-dependent plasticity 6, 8 . Although mGluR5 antagonism rescues many phenotypes associated with FXS, it is unknown whether these phenotypes are due to excess mGluR5-driven translation.
Other evidence suggests there may be altered mGluR5 function that is upstream of translation in Fmr1 −/y brains. Although total mGluR5 levels are normal in Fmr1 −/y forebrain, there is less mGluR5 in the postsynaptic density (PSD) fraction and an altered balance of mGluR5 association with short and long isoforms of the postsynaptic scaffolding protein Homer 10 . The N-terminal EVH1 (Ena-VASP homology) domain of Homer proteins binds the intracellular C-terminal tail of group 1 mGluRs (mGluR5 and mGluR1a) and affects their trafficking, localization and function 11 . Long, constitutively expressed forms of Homer (Homer1b, 1c, 2 and 3) multimerize through their C-terminal coiled-coil domains and localize mGluRs to the PSD through interactions with SHANK (SH3 and multiple ankyrin repeat domains protein), as well as link mGluRs to signaling pathways through Homer interactions with phosphoinositide-3 kinase enhancer (PIKE), elongation factor 2 kinase (EF2K) and the inositol-1,4,5-trisphosphate receptor 11, 12 . Homer1a (H1a), a short, activity-inducible form of Homer, lacks the coiled-coiled domain and cannot multimerize with other Homers. Consequently, H1a disrupts mGluR5-long Homer complexes, alters mGluR signaling and causes constitutive, agonistindependent activity of mGluR1 and mGluR5 (ref. 13) .
In Fmr1 −/y mice, mGluR5 is less associated with the long Homer isoforms and more associated with H1a (ref. 10) . We hypothesized that the altered balance in mGluR5 interactions with Homer isoforms contributes to the mGluR5 dysfunction and pathophysiology of FXS. To test this hypothesis, we crossed Fmr1 −/y mice with mice selectively lacking the H1a isoform of Homer1 (H1a −/− ) and determined whether H1a deletion restored mGluR5 function and Homer interactions, as well as neurophysiological and behavioral phenotypes of Fmr1 −/y mice. In addition, we determined whether acute peptide-mediated disruption of mGluR5-Homer scaffolds in wild-type (WT) mice a r t I C l e S mimics phenotypes of Fmr1 −/y mice. Our results indicate that altered Homer isoform interactions are responsible for much, but not all, of the mGluR5 dysfunction and pathophysiology of FXS. Specifically, H1a deletion did not rescue the protein synthesis independence of mGluR-dependent long-term synaptic depression (mGluR-LTD) or altered translation of FMRP target mRNAs. The latter results support an essential role for FMRP in translational control of its known target mRNAs and mGluR-LTD. Our results provide new evidence for altered mGluR5-Homer scaffolds in Fmr1 knockout phenotypes and implicate different mechanisms of mGluR5 dysfunction in distinct phenotypes. Modulation and restoration of mGluR5-Homer interactions may represent a new therapeutic strategy for FXS and related cognitive and autistic disorders.
RESULTS

Disruption of mGluR5-Homer regulates signaling to translation
To investigate whether the altered mGluR5-Homer scaffolds contribute to the mGluR5 dysfunction in Fmr1 −/y mice, we determined whether disruption of mGluR5-Homer scaffolds with a peptide in WT mice mimics mGluR5 signaling alterations in the Fmr1 −/y mice. The rationale for this approach is based on data that H1a-bound mGluR5, which is increased in the Fmr1 −/y , is functionally equivalent to mGluR5 that cannot interact with any Homer isoform [13] [14] [15] . To disrupt mGluR5-Homer, we incubated acute hippocampal slices from WT mice in a cell-permeable (Tat-fused) peptide containing the proline-rich motif (PPXXF) of the mGluR5 C-terminal tail that binds the EVH1 domain of Homer, mGluR5CT (YGRKKRRQRRR-ALTPPSPFR) 14, 16, 17 . mGluR5CT reduced mGluR5-Homer interactions to 41 ± 6% of that observed in slices with no peptide treatment (n = 3 mice; P = 0.003) as determined by coimmunoprecipitation of mGluR5 and Homer (Fig. 1a) . Notably, mGluR5CT peptide treatment roughly mimicked the 50% decrease in mGluR5-long Homer interaction observed in Fmr1 −/y hippocampal lysates (described below). As a control, slices were incubated in a peptide with a mutated Homer binding motif, mGluR5MU (YGRKKRRQRRR-ALTPLSPRR) 14, 16 . mGluR5MU peptide had no effect on mGluR-Homer by comparison with slices with no peptide treatment (103 ± 8% of untreated; n = 3; Fig. 1a) .
Fmr1 −/y mice show a deficit in stimulation of protein synthesis by mGluR1 and mGluR5 that may be a result of altered mGluR5-Homer interactions. Previously, we reported that mGluR5CT peptide-mediated disruption of mGluR5-Homer interactions in rat hippocampal slices inhibits group 1 mGluR activation of the phosphoinositide-3 kinase (PI3K)-mammalian target of rapamycin (mTOR) protein kinase pathway and of translation initiation. However, mGluR5CT does not inhibit mGluR activation of the mitogen-activated protein kinase 1 (ERK) pathway 17 . Here we observed similar effects in hippocampal slices from WT mice. mGluR5CT peptide incubation blocked activation of PI3K-mTOR pathway in response to the group 1 mGluR agonist (RS)-3,5-dihydroxyphenylglycine (DHPG; 100 µM; 5 min) as measured by phosphorylation of mTOR on Ser2448 and p70 ribosomal S6 kinase (S6K) on Thr389 (phospho-mTOR: mGluR5MU: 196 ± 27% of basal, n = 8; mGluR5CT: 94 ± 20% of basal, n = 8; P < 0.01; phospho-S6K: mGluR5MU: 300 ± 80% of basal, n = 6; mGluR5CT: 114 ± 13% of basal, n = 6; P < 0.05; Fig. 1b,c) and had no effect on activation of the ERK pathway as measured by phosphorylation of ERK on Thr202 and Tyr204 (mGluR5MU: 495 ± 117% of basal, n = 4; mGluR5CT: 477 ± 162% of basal, n = 4; not significant; Fig. 1d ) 17 . The mGluR5CT peptide did not affect basal levels of phospho-mTOR, phospho-S6K or phospho-ERK (Supplementary Table 1) 18 .
Homer and mGluR5 each directly interact with another translational regulatory factor, EF2K 12 . Although phosphorylation of elongation factor 2 (EF2) by EF2K inhibits translation elongation globally, EF2K is required for translational activation of mRNAs npg a r t I C l e S such as Arc (activity-regulated cytoskeleton-associated protein) and Camk2a (calcium/calmodulin-dependent kinase IIα) 12 . A moderate inhibition of elongation globally by EF2K is thought to release translation factors that are then available for translational activation of poorly initiated transcripts. Unexpectedly, mGluR5CT-treated slices showed a robust increase in phosphorylation of EF2 on Thr56 in response to DHPG (590 ± 118% of basal; n = 15 slices, Fig. 1e ) in comparison to mGluR5MU-treated slices (294 ± 63% of basal; n = 15; P < 0.05). Similar results were obtained in rat hippocampal slices (Supplementary Fig. 1 ). The mGluR5CT peptide did not affect basal levels of phospho-EF2 (Supplementary Table 1 ). Taken together, our data suggest that Homer interactions facilitate mGluR activation of the PI3K-mTOR pathway to translation initiation, but dampen mGluR-induced phosphorylation of phospho-EF2 and thus restrain inhibition of global elongation rates. Consequently, disruption of mGluR5-Homer would be expected to block mRNA translation by blocking activation of the PI3K-mTOR pathway and translation initiation and enhancing inhibition of elongation to a level that may block elongation of all transcripts, including Arc. Consistent with this model, disrupting mGluR5-Homer interactions in hippocampal slices with mGluR5CT peptide blocked DHPG-induced synthesis of Arc (mGluR5MU: 122 ± 5% of untreated, n = 7; mGluR5CT: 95 ± 7% of untreated, n = 7; Supplementary Fig. 1 ) and elongation factor 1α (EF1α) 17 .
Deletion of Homer1a rescues mGluR signaling in Fmr1 −/y mGluR5-long Homer interactions are reduced in Fmr1 −/y mice, and we hypothesize that this contributes to altered mGluR5 function. If so, then mGluR signaling to translation in Fmr1 −/y slices may mimic what is observed with mGluR5CT peptide treatment of WT slices (Fig. 1) .
In support of our hypothesis, DHPG-induced activation of PI3K, mTOR and S6K is deficient in Fmr1 −/y hippocampal slices, and ERK activation is unaffected [18] [19] [20] (Fig. 2b) . Furthermore, DHPG-induced phosphorylation of EF2 was enhanced in Fmr1 −/y slices relative to that in slices from WT littermates (WT: 787 ± 135% of untreated, n = 7 mice; Fmr1 −/y : 1,452 ± 176% of untreated, n = 6 mice; 10 , coimmunoprecipitation of long Homer isoforms from Fmr1 −/y forebrain revealed a reduced association of mGluR5 in comparison to that in WT littermates (Fig. 2a) , whereas coimmunoprecipitation of H1a revealed an increased association with mGluR5 ( Supplementary Fig. 2 ). Total levels of mGluR5 and long Homer proteins and of H1a protein and mRNA in Fmr1 −/y hippocampi were not different from those in WT ( Fig. 2a and Supplementary Fig. 2 ). Genetic deletion of H1a restored normal mGluR5-Homer interactions in Fmr1 −/y mice (n = 4 mice per genotype; Fig. 2a ) but did not affect levels of mGluR5, long Homers or their interactions on a WT background ( Fig. 2a and Supplementary Fig. 2 ) 21 . To determine whether H1a deletion restored normal mGluR5 signaling in Fmr1 −/y mice, we examined mGluR signaling to the mTOR and EF2K translational regulatory pathways. The deficit in mGluR5 signaling to mTOR in the Fmr1 −/y , as measured by S6K Thr389 phosphorylation (WT: 242 ± 34% of basal, n = 21; Fmr1 −/y : 135 ± 15%, n = 19; Fig. 2b ), was restored in the H1a −/− Fmr1 −/y (220 ± 28% of untreated, n = 18). Similarly, enhanced mGluR activation of EF2K was rescued to WT levels by Figure 2 mGluR5-Homer scaffolds and group 1 mGluR signaling are altered in Fmr1 -/y mice and rescued by genetic deletion of H1a. (a) Decreased mGluR5-long Homer interactions in the Fmr1 -/y hippocampus were restored to WT levels in H1a -/-Fmr1 -/y littermates. mGluR5 coimmunoprecipitation (IP) with Homer was quantified and normalized to immunoprecipitated Homer. Left: representative blots (IB) from one set of littermates reveal a decrease in the amount of mGluR5 that coimmunoprecipitated with Homer in Fmr1 -/y that was reversed in the H1a -/-Fmr1 -/y mouse. One-fifth of the input for the IP was run on separate blots and demonstrates normal levels of mGluR5 and Homer across all genotypes. Right: group data from independent co-IPs in four litters reveal a reliable decrease in mGluR5-Homer co-IP (expressed as a ratio of immunoprecipitated mGluR5/Homer) in Fmr1 -/y mice and rescue by H1a deletion. (b) Treatment of acute hippocampal slices from littermates of each of the four genotypes with DHPG (100 µm; 5 min) revealed a deficit in phosphorylation of S6K in Fmr1 -/y mice that was restored to WT levels in the H1a -/-Fmr1 -/y . Left: representative western blots of phospho-S6K (P-S6K) and total ERK (loading control) in the basal (B) condition and DHPG (D) treated slices. Right: group data of P-S6K/ERK ratio (normalized to basal levels in untreated slices from the same mouse). n = 14-21 slices per condition from 14-21 mice. (c) DHPG-induced EF2 phosphorylation was enhanced in Fmr1 -/y slices, an effect that was reversed in H1a -/-Fmr1 -/y . Left: representative western blot of P-EF2 and β-tubulin in the basal (B), or untreated, condition and DHPG (D) treated slices from each genotype. Right: group data for P-EF2/tubulin ratio (normalized to basal levels). n = 6 or 7 slices and mice per genotype. *P < 0.05, **P < 0.01; ***P < 0.001; error bars, s.e.m. H1a −/− mice showed normal DHPG-induced phosphorylation of EF2 (796 ± 159% of untreated, n = 6) and S6K (227 ± 34% of treated, n = 14). There was no effect of Fmr1 or H1a genotype on basal levels of phosphorylated or total EF2 or S6K (Supplementary Table 2) . Furthermore, DHPG treatment did not alter levels of total EF2 or S6K in any genotype (Supplementary Table 2 ) 17, 19 .
H1a deletion rescues enhanced translation rates in Fmr1 −/y Although DHPG-induced translation is absent in Fmr1 −/y mice, basal translation rates in brain are elevated 2, 8, 20, 22 . Enhanced protein synthesis in hippocampal slices was reversed by pharmacological blockade of mGluR5 or of ERK activation, but not by an inhibitor of PI3K or of mTOR 20 ( Fig. 3 and Supplementary Fig. 3 ). Another consequence of mGluR5-H1a interactions is constitutive, or agonistindependent, mGluR5 activity 13 , which may drive translation rates through ERK activation, a pathway that remains intact in Fmr1 −/y mice and with Homer disruption (Fig. 1d) 18, 20 . In support of this hypothesis, genetic deletion of H1a rescued enhanced translation rates as measured by incorporation of 35 with eIF4G from hippocampal slices. DHPG (D) induced an increase in eIF4E association with eIF4G, forming the eIF4F translation initiation complex, in WT but not in Fmr1 -/y littermates despite an elevated level of eIF4F complex under basal (B) conditions. H1a deletion alone had no effect on eIF4F complex levels under basal or DHPG-stimulated conditions, whereas H1a deletion on the Fmr1 -/y background reversed the enhanced eIF4F complex levels and restored DHPG-induced eIF4F complex formation. Right: quantified group data for eIF4E coimmunoprecipitating with eIF4G (eIF4F complex) in DHPG-treated samples (normalized to the value in basal, or untreated, slices). n = 3 mice per genotype. (e) Left: representative western blots of phospho-and total ERK and translation initiation factors that are regulated by ERK (phospho-and total eIF4E and 4EBP) from cortical homogenates in each of four genotypes. Right: quantified group data reveal elevated phospho (P)-4EBP and P-eIF4E in Fmr1 -/y brains as compared to WT, which is rescued by H1a deletion. P-ERK levels were not different across any genotype (n = 4-6 mice per genotype). (f) Left: representative western blots from acute hippocampal slices prepared from WT and Fmr1 -/y mice treated with MPEP (10 µM) or vehicle (H 2 O). Right: quantified group data for phosphoproteins in MPEP-treated slices expressed as a percentage of that in basal (untreated) slices reveal a genotypic difference in P-4EBP (Ser65) and P-eIF4E but not P-ERK (n = 2 slices per mouse; 4-8 mice per condition). *P < 0.05; **P < 0.01; ***P < 0.001; error bars, s.e.m. Full-length western blots for this figure are shown in Supplementary Figure 9 .
npg a r t I C l e S 4 mice; double H1a −/− Fmr1 −/y : 106 ± 6% of WT, n = 7 slices from 4 mice; Fig. 3a) . Furthermore, mGluR5CT peptide-mediated disruption of mGluR5-Homer in WT slices was sufficient to mimic the enhanced protein synthesis rates observed in Fmr1 −/y slices (mGluR5CT = 123 ± 6% of mGluR5MU treated, n = 16 slices per peptide from 10 mice; P = 0.002; Fig. 3b ). In contrast, mGluR5CT had no effect on protein synthesis rates in Fmr1 −/y slices (mGluR5CT = 106 ± 8% of mGluR5MU treated, n = 14 (mGluR5CT) or 15 (mGluR5MU) slices from 8 mice; P = 0.5; Fig. 3b ).
Translation initiation is the rate-limiting step in translation 23 . To determine whether enhanced translation rates in the Fmr1 −/y stem from increased initiation, we measured eIF4F translation initiation complexes in hippocampal slices prepared from WT, Fmr1 −/y , H1a −/− and H1a −/− Fmr1 −/y mice. The eIF4F complex is composed of the 5′ cap binding protein eIF4E, the scaffolding protein eIF4G and the RNA helicase eIF4A 23 . eIF4F complex assembly can be measured by coimmunoprecipitation of eIF4G and eIF4E and is stimulated by DHPG in WT animals 24 . Therefore, we also measured eIF4F complex in DHPG-stimulated slices from each genotype. Consistent with previous reports 19 , eIF4F complex levels were enhanced basally in Fmr1 −/y slices and no longer stimulated by DHPG (Fig. 3d) . Like 35 S-labeled methionine and cysteine incorporation, eIF4F complex levels in Fmr1 −/y slices were restored to WT levels by H1a deletion ( Fig. 3d ; n = 3 mice per condition). Genetic deletion of H1a also rescued the deficit in DHPG-stimulated eIF4F complex assembly in the Fmr1 −/y (Fig. 3d) . These results suggest that elevated protein synthesis rates in Fmr1 −/y mice are due to enhanced translation initiation that is driven by H1a-bound mGluR5. The deficit in mGluR-stimulated translation initiation in Fmr1 −/y mice may be because eIF4F complex levels are saturated basally. Furthermore, mGluR-activation of mTOR is rescued in Fmr1 −/y mice by H1a deletion (see Fig. 2 ), which may also contribute to restoration of DHPG-induced eIF4F complex assembly 24 .
To determine how increased H1a-mGluR5 interactions lead to enhanced signaling to translation downstream of ERK, we examined phosphorylation of initiation factors known to be regulated by ERK in WT and Fmr1 −/y cortical homogenates and the effects of H1a deletion. ERK phosphorylates and activates MAPK-interacting kinase (Mnk), which in turn phosphorylates the cap-binding protein eIF4E on Ser209 (ref. 23) . ERK also phosphorylates eIF4E binding protein (4EBP) at Ser65, a site distinct from mTOR-regulated sites (Thr36 and Thr45) 25 . ERK-dependent phosphorylation of eIF4E and 4EBP (Ser65) is associated with increased translation rates in neurons and other cell types 24, 26 . Consistent with a role for ERK in phosphorylation of these initiation factors in hippocampal slices, phospho-(Ser209)-eIF4E and phospho-(Ser65)-4EBP were strongly reduced or abolished by treatment with U0126, an inhibitor of the upstream kinase that 
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** *** ** * Figure 10 . Group averages reveal a deficit in DHPG-induced Arc synthesis slices taken from Fmr1 -/y (n = 10 mice) and H1a -/-Fmr1 -/y (n = 11) mice. DHPG induced Arc synthesis in both WT (n = 12) and H1a -/-(n = 14) littermates. *P < 0.05; **P < 0.01; ***P < 0.001; error bars, s.e.m. Fig. 4 ). Phospho-4EBP and phospho-eIF4E levels were enhanced in cortical homogenates from Fmr1 −/y mice, an effect that was rescued by H1a deletion (Fig. 3e) . As reported in hippocampal slices (Fig. 1d) 17, 20 , phospho-ERK levels were unchanged in Fmr1 −/y lysates (Fig. 3e) .
npg a r t I C l e S activates ERK (MAP/ERK kinase; MEK) (Supplementary
To determine whether mGluR5 activity abnormally drives phosphorylation of ERK, eIF4E and 4EBP (Ser65) in Fmr1 −/y mice, we treated hippocampal slices from both WT and Fmr1 −/y mice with the mGluR5 inverse agonist 2-methyl-6-(phenylethynyl)pyridine (MPEP; 10 µM). MPEP treatment did not affect phospho-4EBP or phospho-eIF4E in WT slices. However, in Fmr1 −/y slices, MPEP reduced phospho-4EBP and phospho-eIF4E by ~50% (Fig. 3f) . Unexpectedly, MPEP had no effect on phospho-ERK levels in either WT or Fmr1 −/y slices. These results support our hypothesis that H1a-mediated mGluR5 activity drives translation initiation through ERK phosphorylation of initiation factors. Because phospho-ERK levels are not affected by Fmr1 knockout or with MPEP, this suggests that mGluR5 may regulate accessibility or localization of eIF4E or 4EBP with ERK, as opposed to ERK activity per se.
Altered LTD is not rescued by deletion of H1a
In WT animals, mGluR-dependent LTD in the CA1 region of the hippocampus requires dendritic protein synthesis of FMRP-interacting mRNAs such as Arc and Mtap1b (also known as Map1b) 5, 12, 27 . Although mGluR activation induces robust LTD in Fmr1 −/y mice, mGluR-induced synthesis of Arc and Map1b is deficient and LTD is independent of new protein synthesis 5, 12 . From this result, it has been suggested that loss of FMRP-mediated translational suppression leads to enhanced steady-state levels of 'LTD proteins' that allow mGluR-LTD to persist without new protein synthesis 5 . Consistent with this hypothesis, elevated Map1b and Arc have been reported in Fmr1 −/y neurons 5, 28 . Alternatively, H1a-bound and constitutively active mGluR5, which drives total protein synthesis rates (Fig. 3) 20 , could elevate LTD protein levels and lead to protein synthesisindependent LTD.
To distinguish between these possibilities, we determined whether genetic deletion of H1a reverses the protein synthesis independence of mGluR-LTD and enhances levels of specific FMRP target mRNAs. To test the protein synthesis dependence of mGluR-LTD, we preincubated slices in the translation inhibitor cycloheximide (60 µM). Although mGluR-LTD was reliably induced with DHPG in H1a −/− Fmr1 −/y mice (81 ± 3% of baseline 60-70 min after DHPG application, n = 11 slices), LTD was not sensitive to cycloheximide (78 ± 1% of baseline, n = 9), and was similar to that in Fmr1 −/y mice (control: 74 ± 4% of baseline, n = 7; cycloheximide: 79 ± 3% of baseline, n = 9; Fig. 4) 12 . LTD was inhibited by cycloheximide treatment in both WT (control: 76 ± 1% of baseline, n = 7; cycloheximide: 92 ± 4% of baseline, n = 8; P = 0.002) and H1a −/− mice (control: 65 ± 5% of baseline, n = 6; cycloheximide: 88 ± 5% of baseline, n = 6; P = 0.01; Fig. 4a,d) . These results suggest that the altered mGluR5-Homer scaffolds in Fmr1 −/y mice do not mediate the protein synthesis independence of mGluR-LTD.
To determine whether H1a deletion in Fmr1 −/y mice rescues elevated steady state levels of LTD-promoting proteins or other FMRP target mRNAs, we performed western blots of Map1b, Arc and CaMKIIα in hippocampal homogenates of WT, Fmr1 −/y , H1a −/− and H1a −/− Fmr1 −/y mice (Fig. 4e) . Map1b and CaMKIIα were elevated in both Fmr1 −/y mice and H1a −/− Fmr1 −/y mice in comparison to WT and H1a −/− mice (Fig. 4e) , indicating that H1a deletion does not restore normal levels of Map1b and CaMKIIα in Fmr1 −/y mice. Although we did not detect elevated steady-state protein levels of Arc in hippocampal homogenates from Fmr1 −/y mice, we observed a deficit in DHPG-induced synthesis of Arc in hippocampal slices from Fmr1 −/y mice in comparison to WT (WT: 140 ± 17% of basal or untreated, n = 12; Fmr1 −/y : 98 ± 12% of untreated, n = 12; Fig. 4f) . However, H1a deletion did not restore mGluR-induced synthesis of Arc in Fmr1 −/y mice 12 (H1a −/− Fmr1 −/y : 91 ± 12% of untreated, n = 11). DHPGinduced synthesis of Arc was normal in H1a −/− mice (139 ± 11% of untreated, n = 11). These results show that altered mGluR5-Homer scaffolds in the Fmr1 −/y mice do not mediate abnormal mGluR-LTD or altered translational control of specific FMRP target mRNAs. Instead, these results support an essential role for interaction of FMRP with its target mRNAs in mGluR-LTD and translational control of these mRNAs 2, 29 .
mGluR5-Homer and hyperexcitable neocortical circuits
Humans with FXS and Fmr1 −/y mice show sensory hypersensitivity, epilepsy and/or audiogenic seizures suggestive of an underlying sensory circuit hyperexcitability 3, 8 . We recently discovered synaptic and circuit alterations indicative of hyperexcitability in the somatosensory In contrast, treatment of Fmr1 -/y slices (n = 12) with CT peptide had no effect on UP state duration in comparison to MU treatment (n = 15). **P < 0.01; ***P < 0.001; error bars, s.e.m. npg a r t I C l e S barrel neocortex of Fmr1 −/y mice. Neocortical slices of Fmr1 −/y mice have decreased excitatory drive onto layer 4 fast-spiking interneurons and prolonged thalamically evoked and spontaneously occurring persistent activity, or UP, states 30, 31 . UP states represent a normal physiological rhythm generated by the recurrent neocortical synaptic connections and are observed in alert and slow-wave sleep states in vivo, as well as in neocortical slice preparations 32, 33 . Of note, genetic or pharmacological reduction of mGluR5 in Fmr1 −/y mice rescues the prolonged UP states in acute slices and in vivo 31 . To determine whether altered mGluR5-Homer interactions contribute to altered neocortical circuit function and hyperexcitability in Fmr1 −/y mice, we measured spontaneously occurring UP states in acute slices from somatosensory barrel cortex using extracellular multiunit recordings 32 . As previously reported 30, 31 , UP states were longer in slices from Fmr1 −/y mice than in those from WT littermates (WT: 797.4 ± 31.5 ms, n = 22 slices; Fmr1 −/y : 1,212 ± 87.9 ms, n = 13; Fig. 5a,b) .
In support for a role for altered Homer interactions, UP state duration was shortened to WT levels by H1a deletion (H1a −/− Fmr1 −/y : 872.2 ± 42.1 ms, n = 44; Fig. 5a,b) . Loss of H1a alone did not affect UP states, ruling out general alterations in excitability (H1a −/− : 767.7 ± 35.8 ms, n = 18). We next determined whether mGluR5CT peptide-mediated disruption of mGluR5-Homer was sufficient to prolong UP states in WT slices. Preincubation of WT neocortical slices in mGluR5CT peptide increased the duration of UP states in comparison to treatment with mGluR5MU control peptide (WT mGluR5MU: 909.8 ± 103.7 ms, n = 13 slices; WT mGluR5CT: 1,408.8 ± 156.4 ms, n = 15; Fig. 5c,d) . Therefore, acute disruption of mGluR5-Homer complexes is sufficient to mimic the circuit hyperexcitability in Fmr1 −/y mice. In contrast, mGluR5CT had no effect on the duration of UP states in Fmr1 −/y slices (Fmr1 −/y mGluR5MU: 2,014.9 ± 117.9 ms, n = 15; Fmr1 −/y mGluR5CT: 1,819.8 ± 163.8 ms, n = 12; Fig. 5c,d) , likely because Homer complexes are already disrupted in these mice.
H1a deletion reverses Fmr1 −/y behavioral phenotypes To determine whether H1a deletion rescues any in vivo or behavioral phenotypes in Fmr1 −/y mice, we measured the incidence of audiogenic seizures and anxiety as measured using the open field activity test across the four genotypes. We chose these phenotypes because they are robust in the C57BL6 strain of Fmr1 −/y mice and sensitive to mGluR5 antagonists 8 . Consistent with previous reports, Fmr1 −/y mice showed increased seizure incidence and severity upon exposure to a loud sound relative to WT and H1a −/− mice, who exhibited little or no incidence of seizure (seizure score (0-3; 3 being most severe; see Online Methods): WT, 0.12 ± 0.12; n = 16 mice; H1a −/− : 0.04 ± 0.04; n = 24; Fmr1 −/y : 1.6 ± 0.2; n = 39; P < 0.001, Fmr1 −/y versus WT or H1a −/− ; Fig. 6a and Supplementary Table 3) . H1a −/− Fmr1 −/y mice responded with a reduced incidence and severity of seizure in comparison to Fmr1 −/y littermates (H1a −/− Fmr1 −/y mice, seizure score 1.1 ± 0.2; n = 37; P < 0.05, H1a −/− Fmr1 −/y versus Fmr1 −/y ). However, H1a −/− Fmr1 −/y mice showed increased seizures in comparison to WT or H1a −/− mice (P < 0.001; Fig. 6a) . Such a partial rescue of the audiogenic seizures by H1a deletion is similar to what is observed with genetic reduction of mGluR5 in Fmr1 −/y mice 7 .
As previously reported, Fmr1 −/y mice spent more time in the center of a lit open field than WT littermates, which has been interpreted as reduced generalized anxiety in the mice 34 ( Fig. 6b; WT, 85 ± 8 s; n = 18 mice; Fmr1 −/y , 138 ± 12; n = 24; P < 0.01). H1a −/− mice did not differ from WT mice in this behavior (H1a −/− , 75 ± 10 s; n = 17). We found that H1a −/− Fmr1 −/y mice behaved like WT mice (H1a −/− Fmr1 −/y , 91 ± 10 s; n = 17), spending significantly less time than Fmr1 −/y mice (P < 0.01) in the center of an open arena. There were no differences in locomotor activity between any of the genotypes ( Supplementary  Fig. 5 ). Therefore, H1a deletion completely rescued the open field activity phenotype, suggesting that altered mGluR5-Homer interactions contribute to altered behavior in Fmr1 −/y mice and may be relevant for altered behaviors in people with FXS.
DISCUSSION Two mechanisms for mGluR dysfunction in FXS
Here we demonstrate a causative role for reduced Homer scaffolds in mGluR5 dysfunction in a model of human neurological disease. MGluR5 dysfunction in animal models of FXS is well established, and genetic or pharmacological reduction of mGluR5 activity reduces or rescues many disease phenotypes in animal models 8 and most recently in patients 9 . However, the molecular basis for mGluR5 dysfunction in FXS was essentially unknown. It has been suggested that loss of an FMRP-mediated translational 'brake' downstream of mGluR5 leads to enhanced mGluR5 function 6, 8 , but this mechanism cannot account for the deficits in mGluR5 signaling or translation-independent dysfunction of mGluR5 associated with FXS 18, 31 .
Our results reveal two mechanisms for mGluR5 dysfunction in Fmr1 −/y mice. First, an imbalance of mGluR5 interactions from long to short Homer1a isoforms leads to altered mGluR5 signaling, enhanced basal translation rates, neocortical hyperexcitability, audiogenic seizures and open field activity (Supplementary Fig. 6a ). Because H1a-bound mGluR5 is constitutively active or agonist independent, our results strongly suggest that the therapeutic action of mGluR5 inverse agonists, such as MPEP 13 , in FXS phenotypes are due, in part, to inhibition of H1a-bound, constitutively active mGluR5. Second, our results reveal that disrupted Homer scaffolds in Fmr1 −/y mice cannot account for altered mGluR-LTD or abnormal translational control of FMRP target mRNAs (Supplementary Fig. 6b ) and implicate an essential role for FMRP binding to and translational regulation of specific mRNAs in mGluR-LTD. The discovery that altered Homer scaffolds account for much of the complex dysfunction of mGluR5 in FXS will help to develop alternative, targeted therapies for the disease and provide mechanistic links to other genetic causes of autism.
Homer scaffolds coordinate mGluR regulation of translation Our data demonstrate new functions of Homer scaffolds in coordination of mGluR-stimulated translation by facilitating activation npg a r t I C l e S of the PI3K-mTOR pathway and translation initiation 18 , as well as limiting activation of EF2K and subsequent inhibition of elongation. Homer links to PIKE, a small GTPase that binds and activates PI3K in response to mGluR activation 11 . The PI3K pathway stimulates mTOR to phosphorylate eIF4E binding protein (4EBP), which in turn releases eIF4E to interact with eIF4G and form the eIF4F translation initiation complex 23 . Furthermore, mTOR phosphorylates S6K to stimulate translation of 5′ terminal oligopyrimidine tract (5′ TOP) mRNAs that encode ribosomal proteins and translation factors, thus increasing the translational capacity of the cell 23 . mGluR activation of the PI3K-mTOR-S6K pathway was blocked by mGluR5CT, and the deficits in mGluR activation of mTOR and initiation complex (eIF4F) formation in Fmr1 −/y mice were restored by H1a deletion, indicating that Homer scaffolds are key for mGluR-stimulated translation initiation 18 . Although somewhat counterintuitive given the fact that mGluRs stimulate translation initiation, mGluRs also stimulate phosphorylation of EF2, which inhibits elongation rate 12 . EF2K and moderate inhibition of elongation are necessary for mGluR-induced synthesis of Arc, as well as mGluR-LTD 12 . Submaximal inhibition of global elongation may make available rate-limiting factors to translate mRNAs that are poorly initiated and cannot compete effectively for these factors 35 . Long Homer interactions limit EF2K activation by mGluRs and thus would be expected to temper mGluR-mediated inhibition of general elongation and, in turn, promote translation of poorly initiated mRNAs 12 . Consequently, disruption of mGluR5-Homer enhances EF2K activity and would be expected to strongly inhibit elongation and block translational activation. Although we did not rescue abnormal mGluR-LTD in Fmr1 −/y neurons by deletion of H1a, in WT slices mGluR5CT peptide treatment blocked mGluR-induced synthesis of Arc and mGluR-LTD 18 . These results indicate that in WT neurons, where mGluR-LTD requires de novo protein synthesis, mGluR5-Homer interactions are necessary to properly stimulate translation and induce LTD.
In Fmr1 −/y mice there was a deficit in mGluR stimulation of PI3K-mTOR and eIF4F initiation complex formation, whereas EF2K activation was markedly enhanced. These changes would be expected to block mGluR-induced translational initiation and strongly inhibit elongation. mGluR-induced rapid synthesis of many proteins (for example, PSD-95, EF1α, amyloid precursor protein, Arc, CaMKIIα and Map1b) is absent in Fmr1 −/y mice 2 , which may be mediated, in part, by disrupted mGluR-Homer scaffolds and altered signaling to the translation machinery. Alternatively or in addition, because FMRP interacts with these mRNAs, it is likely required for mGluRtriggered translational activation of specific target mRNAs 2, 29 . The fact that H1a deletion rescues mGluR-mediated translation initiation complex formation but not synthesis of Arc suggests a requirement for both mGluR5-Homer scaffolds and FMRP in mGluR-triggered Arc translation.
Altered mGluR5-Homer scaffolds increase translation rates
Although there is a deficit in mGluR agonist-stimulated translation in Fmr1 −/y mice, steady-state translation rates and levels of specific proteins are elevated 19, 20 , thus reflecting the complexity of translational control. Because one function of FMRP is to suppress translation of its mRNA targets 2 , an obvious possibility was that the elevated protein synthesis rates and protein levels directly result from loss of FMRP-mediated suppression of mRNA targets. In support of this hypothesis, H1a deletion does not reverse enhanced protein levels of Map1b and CaMKIIα. However, elevated total protein synthesis rates and translation initiation (eIF4F) complexes were rescued by H1a deletion and mimicked in WT mice by mGluR5CT peptide treatment.
Thus, increased steady-state translation rates in Fmr1 −/y tissue are a result of altered mGluR5-Homer scaffolds that are a secondary consequence of FMRP loss. Elevated protein synthesis rates in Fmr1 −/y hippocampal slices are reversed by the genetic reduction of mGluR5 (Grm5 +/− ), the mGluR5 inverse agonist MPEP and inhibitors of ERK 8, 20 . In Fmr1 −/y cortical lysates, we observed enhanced phosphorylation of translation initiation factors that are downstream of ERK (eIF4E and 4EBP) that was reversed by H1a deletion. Furthermore, blocking mGluR5 activity with MPEP strongly reduced phosphoeIF4E and phospho-4EBP in Fmr1 −/y , but not WT, hippocampal slices. Together these results suggest that H1a-bound and constitutively active mGluR5 in Fmr1 −/y neurons 13 drives ERK-dependent phosphorylation of eIF4E and 4EBP, which enhances eIF4F initiation complex formation and translation rates. Because we do not observe an effect of Fmr1 −/y or MPEP on phospho-ERK levels as detected by western blot, this suggests that mGluR5 either drives ERK activity that is not detectable by phosphorylation at Thr202 and Tyr204 and/or regulates accessibility of eIF4E and 4EBP to ERK.
In contrast to hippocampus, recent results from neocortical synaptoneurosomes of Fmr1 −/y mice demonstrate a role for PI3K activity in enhanced protein synthesis rates 22 . We observed that the PI3K inhibitor wortmannin equalized translation rates between WT and Fmr1 −/y hippocampal slices, but this was because wortmannin actually increased translation rates in WT, but not Fmr1 −/y , slices (Supplementary Fig. 3) . Furthermore, elevated basal phosphorylation of PI3K, mTOR and 4EBP (at the mTOR sites) was recently reported in fresh hippocampal lysates of Fmr1 −/y mice, perhaps as a result of increased PIKE 19, 20 . Although we are unable to detect elevated basal activation of the PI3K-mTOR pathway in our slice preparation 18 , persistent activation of downstream effectors of PI3K and mTOR together with constitutive mGluR5-driven ERK may elevate translation rates in Fmr1 −/y mice. Phospho-EF2 levels are unchanged in Fmr1 −/y slices, suggesting that basal or constitutive mGluR5 activity is not sufficient to activate EF2K. The detailed mechanisms by which ERK, PI3K and mTOR, and EF2K contribute to elevated basal protein synthesis rates in Fmr1 −/y mice requires further study and may differ depending on the brain region, subcellular compartment or preparation.
H1a deletion and restoration of mGluR5-Homer scaffolds in Fmr1 −/y mice did not rescue the protein synthesis independence of mGluR-LTD nor elevated steady-state levels of Map1b and CaMKIIα proteins produced from FMRP target mRNAs. This supports the hypothesis that the protein synthesis independence of mGluR-LTD in Fmr1 −/y mice is a result of loss of FMRP-mediated translational suppression of LTD-promoting proteins, such as MAP1b 36 . Because H1a deletion rescued the elevated incorporation of 35 S-labeled methionine and cysteine, but not altered mGluR-LTD and enhanced MAP1b and CaMKIIα levels, this suggests that altered LTD and elevated MAP1b and CaMKII are not a result of elevated total protein synthesis rates. Furthermore, the fact that mGluR-triggered Arc synthesis was not rescued by H1a deletion supports an essential role for FMRP in mGluRtriggered translational activation of Arc. Recent work has implicated mGluR-triggered dephosphorylation of FMRP in translational activation of FMRP target mRNAs, such as Dlgap3 (SAPAP3) and Dlg4 (PSD95) (refs. 2,29) .
Altered mGluR5-Homer and neocortical network dysfunction Altered neocortical circuit function and hyperexcitability have been predicted to contribute to cognitive disorders and autism 37, 38 . The epilepsy and electroencephalographic abnormalities observed in people with FXS are indicative of brain hyperexcitability 3, 8 . Furthermore, these individuals are hypersensitive to sensory stimuli, and Fmr1 −/y npg a r t I C l e S mice have audiogenic seizures reflecting hyperexcitability of sensory circuits 3, 8 . Although UP states are a normal physiological rhythm and are not epileptiform activity, they provide an effective readout of the state of circuit function and excitability 32 . Furthermore, UP states underlie the slow oscillations that occur during slow wave sleep and are implicated in memory consolidation, as well as sensory processing in waking states 33 How does mGluR5 activity lead to longer UP states? Prolonged UP states are not due to mGluR5-driven translation, because the protein synthesis inhibitor anisomycin does not affect UP state duration in either WT or Fmr1 −/y slices 31 . Therefore, mGluR5 activity likely leads to prolonged UP states through post-translational regulation of the intrinsic excitability and/or synaptic function of neocortical neurons.
Altered behavior in Fmr1 −/y mice is rescued by H1a deletion Genetic reduction of mGluR5 (heterozygosity), or H1a deletion, completely rescues neocortical hyperexcitability (for example, long UP states) in Fmr1 −/y mice, but only partially rescues audiogenic seizures 7, 31 . This suggests that hyperexcitability in other brain regions, such as the auditory brain stem, also contributes to audiogenic seizures in Fmr1 −/y mice, through mechanisms independent of mGluR5 and H1a 40 . Notably, mGluR5 antagonism and H1a deletion rescued the increased open field activity in Fmr1 −/y mice, suggesting that abnormal Homer scaffolds contribute to behavioral symptoms associated with FXS and may represent a new therapeutic target for the disease. In contrast to initial studies 7, 8, 20 , recent reports have failed to rescue some Fmr1 −/y mouse behaviors by reduction of mGluR5 activity 41, 42 , suggesting mGluR5-independent mechanisms in FXS pathology. Of note, in these studies inhibition of mGluR1 proved efficacious in reducing some Fmr1 −/y phenotypes 41, 42 . MGluR1a is a Homer binding protein, and mGluR1a-Homer scaffolds may also be affected in Fmr1 −/y mice. Alternatively, because of the diverse mRNA targets of FMRP 43 other signaling pathways are likely affected in FXS. However, because mGluR5 antagonism has proven effective in some FXS patients 9 , the understanding of mGluR5 function in the normal brain and its dysfunction in FXS may provide additional and more targeted treatments for the disease and provide insight into autism.
For the phenotypes we studied here, H1a deletion had no effect in the WT background but only in the Fmr1 −/y background. This is likely because H1a expression is typically low under basal conditions and is strongly induced in response to neuronal activity and experience 11 . The effects of H1a induction in WT mice are expected to be mimicked by the mGluR5CT peptide, where we observe effects on mGluR5 signaling, protein synthesis rates, LTD 18 and UP state duration. In contrast, mGluR5CT peptide has no effect on these measures in Fmr1 −/y mice 18 . Therefore, we would expect that experience-dependent H1a induction would affect mGluR5 function in WT, but not Fmr1 −/y , mice. Such insensitivity to experience-induced H1a could contribute to deficits in experience-dependent plasticity associated with FXS 7 .
Mechanism of disrupted Homer scaffolds in Fmr1 −/y How does loss of FMRP lead to altered mGluR5-Homer scaffolds? Protein levels of long Homers and H1a are unchanged in total homogenates of Fmr1 −/y hippocampi 10 , and FMRP is not reported to interact with mRNA for any Homer isoforms 43 . Previous work reported a decrease in tyrosine phosphorylation of long Homer in Fmr1 −/y forebrain 10 , but it is unknown whether or how this affects interactions with mGluR5. Phosphorylation of Homer3 regulates interactions with other Homer effectors 44, 45 . Similarly, phosphorylation of mGluR5 at the C-terminal Homer interaction domain reduces the affinity of mGluR5 for Homer 46 . Therefore, post-translational modification of mGluR5 and/or Homer in Fmr1 −/y mice may underlie the decreased interactions.
Disrupted or destabilized synaptic scaffolds that affect Homer and/or mGluR5 may also contribute more generally to cognitive disorders and autistic behaviors. Mutations in the Homer binding domain of SHANK3 and the Homer binding protein oligophrenin 1 are implicated in autism and intellectual disability, respectively 47, 48 . Expression of a truncated SHANK3 without the Homer binding domain in mice results in degradation of SHANK3 and autistic behaviors in mice. Notably, reduction of long Homers or induction of H1a recapitulates the degradation of synaptic SHANK3 (ref. 47 ). One possibility is that mGluR5 dysfunction of the kind we describe here may occur in individuals with mutations in SHANK3 or other genes that destabilize Homer scaffolds.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
